The comparative study to evaluate the effect of palonosetron monotherapy versus palonosetron with dexamethasone combination therapy for prevention of postoperative nausea and vomiting
Background5-hydroxytryptamine type 3 (5-HT3) receptor antagonists are effective and safe on postoperative nausea and vomiting (PONV). Palonosetron, the newest 5-HT3 antagonist, has potent antiemetic property. We hypothesized that a combination of palonosetron and dexamethasone could more decrease PO...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Anesthesiologists
2012-10-01
|
Series: | Korean Journal of Anesthesiology |
Subjects: | |
Online Access: | http://ekja.org/upload/pdf/kjae-63-334.pdf |
_version_ | 1818562338595274752 |
---|---|
author | Jung Woo Park Jin Woo Jun Yun Hee Lim Sang Seok Lee Byung Hoon Yoo Kye-Min Kim Jun Heum Yon Ki Hyuk Hong |
author_facet | Jung Woo Park Jin Woo Jun Yun Hee Lim Sang Seok Lee Byung Hoon Yoo Kye-Min Kim Jun Heum Yon Ki Hyuk Hong |
author_sort | Jung Woo Park |
collection | DOAJ |
description | Background5-hydroxytryptamine type 3 (5-HT3) receptor antagonists are effective and safe on postoperative nausea and vomiting (PONV). Palonosetron, the newest 5-HT3 antagonist, has potent antiemetic property. We hypothesized that a combination of palonosetron and dexamethasone could more decrease PONV than palonosetron alone.MethodsAmong the patients scheduled to undergo laparoscopic gynecologic surgery, mastoidectomy with tympanoplasty or thyroidectomy under general anesthesia, eighty four female patients with at least two PONV risk factors were enrolled in this study. They were received randomly 0.075 mg palonosetron and 4 mg dexamethasone (group C) or 0.075 mg palonosetron alone (group P). The severity of PONV using Rhodes index and the percentage of complete response during postoperative 24 hours were compared between groups.ResultsThe frequency of mild/moderate/great/severe PONV based on Rhodes index were 9.8%/0%/0%/0% and 9.3%/2.3%/2.3%/0% in group P and group C, respectively. Complete response for PONV was observed in 90.2% and 86% of patients in group P and group C, respectively. The overall incidence of PONV in group P and C was 9.8% and 14%, respectively. There was no significant difference between the two groups.ConclusionsThere were no differences between palonosetron monotherapy and combination therapy of palonosetron and dexamethasone in patients with high emetogenic risk. |
first_indexed | 2024-12-14T01:02:23Z |
format | Article |
id | doaj.art-d536771370794c18a79ec219141d81b0 |
institution | Directory Open Access Journal |
issn | 2005-6419 2005-7563 |
language | English |
last_indexed | 2024-12-14T01:02:23Z |
publishDate | 2012-10-01 |
publisher | Korean Society of Anesthesiologists |
record_format | Article |
series | Korean Journal of Anesthesiology |
spelling | doaj.art-d536771370794c18a79ec219141d81b02022-12-21T23:23:10ZengKorean Society of AnesthesiologistsKorean Journal of Anesthesiology2005-64192005-75632012-10-0163433433910.4097/kjae.2012.63.4.3347431The comparative study to evaluate the effect of palonosetron monotherapy versus palonosetron with dexamethasone combination therapy for prevention of postoperative nausea and vomitingJung Woo Park0Jin Woo Jun1Yun Hee Lim2Sang Seok Lee3Byung Hoon Yoo4Kye-Min Kim5Jun Heum Yon6Ki Hyuk Hong7Department of Anesthesiology and Pain Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.Department of Anesthesiology and Pain Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.Department of Anesthesiology and Pain Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.Department of Anesthesiology and Pain Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.Department of Anesthesiology and Pain Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.Department of Anesthesiology and Pain Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.Department of Anesthesiology and Pain Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.Department of Anesthesiology and Pain Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.Background5-hydroxytryptamine type 3 (5-HT3) receptor antagonists are effective and safe on postoperative nausea and vomiting (PONV). Palonosetron, the newest 5-HT3 antagonist, has potent antiemetic property. We hypothesized that a combination of palonosetron and dexamethasone could more decrease PONV than palonosetron alone.MethodsAmong the patients scheduled to undergo laparoscopic gynecologic surgery, mastoidectomy with tympanoplasty or thyroidectomy under general anesthesia, eighty four female patients with at least two PONV risk factors were enrolled in this study. They were received randomly 0.075 mg palonosetron and 4 mg dexamethasone (group C) or 0.075 mg palonosetron alone (group P). The severity of PONV using Rhodes index and the percentage of complete response during postoperative 24 hours were compared between groups.ResultsThe frequency of mild/moderate/great/severe PONV based on Rhodes index were 9.8%/0%/0%/0% and 9.3%/2.3%/2.3%/0% in group P and group C, respectively. Complete response for PONV was observed in 90.2% and 86% of patients in group P and group C, respectively. The overall incidence of PONV in group P and C was 9.8% and 14%, respectively. There was no significant difference between the two groups.ConclusionsThere were no differences between palonosetron monotherapy and combination therapy of palonosetron and dexamethasone in patients with high emetogenic risk.http://ekja.org/upload/pdf/kjae-63-334.pdfdexamethasonepalonosetronponv |
spellingShingle | Jung Woo Park Jin Woo Jun Yun Hee Lim Sang Seok Lee Byung Hoon Yoo Kye-Min Kim Jun Heum Yon Ki Hyuk Hong The comparative study to evaluate the effect of palonosetron monotherapy versus palonosetron with dexamethasone combination therapy for prevention of postoperative nausea and vomiting Korean Journal of Anesthesiology dexamethasone palonosetron ponv |
title | The comparative study to evaluate the effect of palonosetron monotherapy versus palonosetron with dexamethasone combination therapy for prevention of postoperative nausea and vomiting |
title_full | The comparative study to evaluate the effect of palonosetron monotherapy versus palonosetron with dexamethasone combination therapy for prevention of postoperative nausea and vomiting |
title_fullStr | The comparative study to evaluate the effect of palonosetron monotherapy versus palonosetron with dexamethasone combination therapy for prevention of postoperative nausea and vomiting |
title_full_unstemmed | The comparative study to evaluate the effect of palonosetron monotherapy versus palonosetron with dexamethasone combination therapy for prevention of postoperative nausea and vomiting |
title_short | The comparative study to evaluate the effect of palonosetron monotherapy versus palonosetron with dexamethasone combination therapy for prevention of postoperative nausea and vomiting |
title_sort | comparative study to evaluate the effect of palonosetron monotherapy versus palonosetron with dexamethasone combination therapy for prevention of postoperative nausea and vomiting |
topic | dexamethasone palonosetron ponv |
url | http://ekja.org/upload/pdf/kjae-63-334.pdf |
work_keys_str_mv | AT jungwoopark thecomparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting AT jinwoojun thecomparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting AT yunheelim thecomparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting AT sangseoklee thecomparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting AT byunghoonyoo thecomparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting AT kyeminkim thecomparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting AT junheumyon thecomparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting AT kihyukhong thecomparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting AT jungwoopark comparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting AT jinwoojun comparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting AT yunheelim comparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting AT sangseoklee comparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting AT byunghoonyoo comparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting AT kyeminkim comparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting AT junheumyon comparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting AT kihyukhong comparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting |